REN and peripheral arterial disease: Analysis of medication prescriptions up to 30 days after study enrollment showed that the groups with and without PAD did not differ in the representation of betablockers, 902 (77.3%) vs. 25 (69.4%); p = 0.313, and renin-angiotensin receptor inhibitors, 873 (74.8%) vs. 24 (66.7%); p = 0.330.